Singer Capital Markets is delighted to have been appointed as Nominated Advisor and Sole Broker to SkinBioTherapeutics plc with immediate effect.
SkinBioTherapeutics plc is a UK-based life sciences company focused on skin health. Headquartered in Newcastle upon Tyne, the Company focuses on developing products that harness the skin microbiome to improve skin health.
Ticker: SBTX
Market Cap: £43.89 million*
Website: Click here
*As of 20th May 2025
Account Team
| Investment Banking | |||
|---|---|---|---|
![]() Phil Davies Managing Director,Investment Banking Email | Call |
![]() Sam Butcher Assistant Director.Investment Banking Email | Call |
![]() Patrick Weaver Analyst,Investment Banking Email | Call |
|
| Research and Sales | |||
|---|---|---|---|
![]() Karl Keegan Head of Research Email | Call |
![]() Jonathan Dighe Equity Sales Email | Call |
||
| Investor Relations | |||
|---|---|---|---|
![]() Megan Willson Investor Relations Email | Call |
|||